A Phase 1, Randomized, Double-Blind, Placebo- and Positive−Controlled, 4-Period Crossover Thorough QT Study to Evaluate the Effect of a Single Dose of TD-4208 on Cardiac Repolarization in Healthy Subjects

Trial Profile

A Phase 1, Randomized, Double-Blind, Placebo- and Positive−Controlled, 4-Period Crossover Thorough QT Study to Evaluate the Effect of a Single Dose of TD-4208 on Cardiac Repolarization in Healthy Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2016

At a glance

  • Drugs Revefenacin (Primary) ; Moxifloxacin
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Sponsors Theravance Biopharma
  • Most Recent Events

    • 07 Aug 2016 Last checked against ClinicalTrials.gov record.
    • 02 Aug 2016 Status changed from active, no longer recruiting to completed.
    • 13 Jul 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top